CG Oncology targets near $1 bln valuation in US IPO | Reuters
Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. The company is developing a therapy …
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO | Reuters
4 weeks from now
Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. The company is developing a therapy …
reuters.com
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO
4 weeks from now
Jan 18, 2024 · Adds details on company's business, IPO terms in paragraphs 2-6. Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation …
nasdaq.com
OFF
Cancer Drug Developer CG Oncology Targets Near $1 Bln Valuation …
4 weeks from now
Jan 18, 2024 · Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering.
yahoo.com
OFF
CG Oncology Targets Near $1 Billion Valuation In US IPO - Yahoo …
4 weeks from now
Jan 18, 2024 · The company is developing a therapy for patients with bladder cancer. Biotech investor ORI Capital and life sciences investor Decheng Capital are its biggest shareholders. …
yahoo.com
OFF
UPDATE 2-Cancer Drug Developer CG Oncology Valued At $1.75 …
4 weeks from now
Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …
yahoo.com
OFF
Cancer Drug Developer CG Oncology Valued At $1.75 Billion In …
4 weeks from now
Jan 25, 2024 · (Reuters) -Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new …
usnews.com
OFF
Drug Developer CG Oncology Targets Up To $306 Mln For Upsized IPO
4 weeks from now
Jan 23, 2024 · If the offering is priced at the top end of the indicated range, CG Oncology would be valued at $1.1 billion in the IPO. Morgan Stanley, Goldman Sachs, Cantor and LifeSci …
nasdaq.com
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO
4 weeks from now
Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. The company is developing a therapy for patients...
marketscreener.com
OFF
Cancer Drug Developer CG Oncology Targets Near $1 Bln Valuation …
4 weeks from now
Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. (Reporting by Niket Nishant in Bengaluru; Editing by... …
marketscreener.com
OFF
UPDATE 2-Drug Developer CG Oncology Targets Up To $306 Mln …
4 weeks from now
Jan 23, 2024 · If the offering is priced at the top end of the indicated range, the company would be valued at $1.1 billion in the IPO. From the healthcare space, CG Oncology is looking to test …
yahoo.com
OFF
CG Oncology Targets Near $1 Billion Valuation In US IPO
4 weeks from now
Jan 18, 2024 · CG Oncology is one of a handful of companies from the healthcare sector looking to list in the coming months, as a market rally on hopes of a soft landing for the economy …
aol.com
OFF
Bladder Cancer Biotech CG Oncology Raises $380 Million In IPO
4 weeks from now
Jan 25, 2024 · CG Oncology, a biotech focused on bladder cancer, raised $380 million in its IPO, pricing 20 million shares at $19. Why it matters This is a lustrous green light for the broader …
axios.com
OFF
CG Oncology Prices Larger-than-expected $380M IPO In Hopeful …
4 weeks from now
Jan 24, 2024 · Cancer drug developer CG Oncology has raised $380 million in an initial public offering than was larger than it expected, a positive sign for a sector that’s struggled to …
biopharmadive.com
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO
4 weeks from now
Jan 18, 2024 · Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering.The company is developing a therapy for …
tradingview.com
OFF
CG Oncology Valued At $1.75 Bln In Strong Market Debut - Nasdaq
4 weeks from now
Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as demand for new …
nasdaq.com
OFF
CG Oncology Begins IPO Effort For Bladder Cancer Drug - Seeking …
4 weeks from now
Jan 5, 2024 · Summary. CG Oncology, Inc. has filed for a $100 million IPO to fund the development of its bladder cancer treatment. The company's lead candidate has shown …
seekingalpha.com
OFF
CG Oncology Targets Near $1 Billion Valuation In US IPO
4 weeks from now
Jan 18, 2024 · CG Oncology targets near $1 billion valuation in US IPO. 1/18/24 REUTERS 11:15:46 • ... January 18, 2024 (Reuters) -Cancer drug developer CG Oncology said on …
westlaw.com
OFF
CG Oncology, Inc. (CGON) Stock Price, Quote & News - Stock …
4 weeks from now
5 days ago · Four very small Chinese issuers also began trading in the US this past week, all raising $10 million or less. 10 months ago - Seeking Alpha. Biotech's First IPO of 2024 …
stockanalysis.com
OFF
CG Oncology, Inc. (CGON) Statistics & Valuation Metrics - Stock …
4 weeks from now
Oct 29, 2024 · Total Valuation. CG Oncology has a market cap or net worth of $2.43 billion. The enterprise value is $1.87 billion. Market Cap: 2.43B: Enterprise Value : 1.87B: ... The average …
stockanalysis.com
FAQs about CG Oncology targets near $1 bln valuation in US IPO | Reuters Coupon?
How much is CG oncology worth?
Is CG oncology a good IPO?
Will CG oncology raise $306 million?
Who are CG oncology's biggest shareholders?
Is CG oncology a good buy?
How big is CG oncology's market for bladder cancer treatment?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
